Gurnee, IL, United States of America

Wei Qiu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Qiu. Retrieved from https://idiyas.com/inventor/wei-qiu-etmgh126

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wei Qiu

Introduction

Wei Qiu is an accomplished inventor based in Gurnee, Illinois. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific signaling pathways.

Latest Patents

Wei Qiu holds a patent for "Inhibitors of tyrosine kinase 2 mediated signaling." This patent discloses compounds of Formula (I) and pharmaceutically acceptable salts thereof. The patent also includes pharmaceutical compositions and methods of preparation and use, showcasing his innovative approach to drug development.

Career Highlights

Wei Qiu is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His work focuses on advancing therapeutic solutions that address critical health challenges.

Collaborations

Throughout his career, Wei Qiu has collaborated with notable colleagues, including Maria A. Argiriadi and Eric C. Breinlinger. These partnerships have contributed to the advancement of research and development in their respective fields.

Conclusion

Wei Qiu's innovative work in pharmaceutical sciences and his contributions to the development of targeted therapies highlight his role as a significant inventor in the industry. His patent on tyrosine kinase inhibitors exemplifies the impact of his research on future medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…